Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Leithner

Showing results (381-390 of 404) with videos related to

Pageof 41
Sort By:
Journal of Surgical Oncology|August 25, 2022
A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysisNicholas M Bernthal, John H Healey, Emanuela Palmerini, et al.
The Journal of Pathology|April 23, 2016
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screenSusanne Scheipl, Michelle Barnard, Lucia Cottone, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 23, 2018
Surgery for metachronous metastasis of soft tissue sarcoma - A magnitude of benefit analysis using propensity score methodsMaria A Smolle, Veroniek M van Praag, Florian Posch, et al.
The American Journal of Pathology|February 19, 2013
Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targetsJolieke G van Oosterwijk, Danielle Meijer, Maayke A J H van Ruler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 13, 2023
Effect of radiotherapy on local recurrence, distant metastasis and overall survival in 1200 extremity soft tissue sarcoma patients. Retrospective analysis using IPTW-adjusted modelsMaria A Smolle, Dimosthenis Andreou, Judith Wölfel, et al.
The Journal of Pathology|December 21, 2010
Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based studyNadège Presneau, Asem Shalaby, Hongtao Ye, et al.
The Lancet. Oncology|April 29, 2019
Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort studyMonique J L Mastboom, Emanuela Palmerini, Floortje G M Verspoor, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2025
Conference on challenges in sarcoma (CCS) 2024: Expert opinions on non-evidence-based management aspectsSilvia Hofer, Chantal Pauli, Beata Bode, et al.
Journal of Surgical Oncology|June 8, 2020
Expandable distal femur megaprosthesis: A European Musculoskeletal Oncology Society study on 299 casesEric Lodewijk Staals, Andrea Sambri, Domenico Andrea Campanacci, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2014
Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society studyAnna Maria Frezza, Marilena Cesari, Daniel Baumhoer, et al.
Pageof 41

Showing results (381-390 of 404) with videos related to

Sort By:
Pageof 41
Journal of Surgical Oncology|August 25, 2022
A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysisNicholas M Bernthal, John H Healey, Emanuela Palmerini, et al.
The Journal of Pathology|April 23, 2016
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screenSusanne Scheipl, Michelle Barnard, Lucia Cottone, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 23, 2018
Surgery for metachronous metastasis of soft tissue sarcoma - A magnitude of benefit analysis using propensity score methodsMaria A Smolle, Veroniek M van Praag, Florian Posch, et al.
The American Journal of Pathology|February 19, 2013
Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targetsJolieke G van Oosterwijk, Danielle Meijer, Maayke A J H van Ruler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 13, 2023
Effect of radiotherapy on local recurrence, distant metastasis and overall survival in 1200 extremity soft tissue sarcoma patients. Retrospective analysis using IPTW-adjusted modelsMaria A Smolle, Dimosthenis Andreou, Judith Wölfel, et al.
The Journal of Pathology|December 21, 2010
Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based studyNadège Presneau, Asem Shalaby, Hongtao Ye, et al.
The Lancet. Oncology|April 29, 2019
Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort studyMonique J L Mastboom, Emanuela Palmerini, Floortje G M Verspoor, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2025
Conference on challenges in sarcoma (CCS) 2024: Expert opinions on non-evidence-based management aspectsSilvia Hofer, Chantal Pauli, Beata Bode, et al.
Journal of Surgical Oncology|June 8, 2020
Expandable distal femur megaprosthesis: A European Musculoskeletal Oncology Society study on 299 casesEric Lodewijk Staals, Andrea Sambri, Domenico Andrea Campanacci, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2014
Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society studyAnna Maria Frezza, Marilena Cesari, Daniel Baumhoer, et al.
Pageof 41